The immune response plays an important role in the development of allergic diseases. It is established that a complex network of various immunocytes such as Th2, non-Th2 (Th17), and regulatory T (Treg) participate in allergic reactions. In this study, we examined the frequencies of Th17 cells (IL-17-positive cells) and Treg cells (FOXP3-positive cells) in the peripheral blood and elucidated their participation in pediatric allergic diseases such as bronchial asthma and food allergies. Our study included 35 subjects, 27 with allergic diseases (19 with asthma and 8 with food allergies) and 8 were controls (without any allergic diseases); their age ranged from 1 to 13 years. The frequency of Th17 cells (IL-17-positive cells) among the CD4 + T cells in the peripheral blood was 2.33 ± 1.29% in patients with bronchial asthma, 1.53 ± 1.34% in those with food allergies, and 1.50 ± 0.809% in controls. These results indicated that only the patients with bronchial asthma had a trend towards a higher frequency of Th17 cells (p = 0.1558). The ratio of Th17 cells to Treg cells did not show any statistical correlation among the patients with bronchial asthma. However, when we excluded the patients with a severe type of asthma, we could obtain an inverse trend between the ratio of Th17 cells to Treg cells (p = 0.1655). This study suggested that Th17 cells and Treg cells participate in pediatric allergic reactions such as bronchial asthma.
INTRODUCTION
The prevalence of bronchial asthma shows great regional disparity, with a trend toward higher prevalence in more developed regions, i.e., more hygienic communities. Akashi et al. and others 1, 2) reported that asthma prevalence showed a 2-fold regional variation in Japan, while the International Study of Asthma and Allergies in childhood (ISAAC) Steering Committee 3, 4) reported that global prevalence varies widely from 1.6% to 36.8%.
On the other hand, the prevalence of food allergies was reported to be 3.5-4% (5-10% during infancy and 1-2% during childhood) in Japan 5) and 3.5-4% 6) (6% in children below 3 years of age 7, 8) ) in the U.S.A. Allergic diseases have now become much more common, especially in industrialized countries, and their incidence seems to be increasing worldwide. The rise in the prevalence of allergies and asthma is considered to be a direct and unintended result of the success of modern hygienic practices in preventing childhood infections. Strachan 9) suggested that this rise in the prevalence could be due to "the imbalance of Th1/Th2," and his "hygiene hypothesis" has been widely accepted. However, allergic reactions are quite complicated and sometimes difficult to un- Vol. 56 (2010) derstand using a simple hypothesis. For example, the number of patients with Th1 diseases such as Crohn's disease and rheumatoid arthritis have also increased recently, and Th2, but not Th1, is induced by a stimulus of a low concentration of toll-like receptor 3 (TLR3), which forms a complex with double-stranded RNA. 10) Furthermore, immune T cells other than Th1 and Th2 have been found to exhibit a close relationship with the recent increase in autoimmune diseases.
Regulatory T cells (Treg cells) are a specialized subpopulation of T cells that suppress the activation of the immune system and thereby maintain both the homeostasis of the immune system and tolerance to self-antigens. In 1995, Sakaguchi et al. 11) found that Tregs had a CD4 + CD25 + immunophenotype and subsequent studies have identified that FOXP3 was its master regulatory gene. [12] [13] [14] Tregs account for about 10% of CD4 + T cells in the peripheral blood and consist of 2 major classes: the thymusderived naturally occurring Treg and peripheraldifferentiated adaptive Treg. Naturally occurring Tregs are important for maintaining self-tolerance, while the adaptive Tregs are thought to be induced in the periphery where they regulate immune responses at local inflammatory sites. 13, 14) Th17 cells, which are considered developmentally distinct from Th1 and Th2 cells, were found to be a subset of Th cells, which participate in the increased prevalence of allergies and asthma. Infante-Duarte et al. 15) first reported that Th17 cells were IL-17-secreting T cells in 2000. IL-17 induces the production of inflammatory cytokines or chemokines, which increases neutrophil recruitment into tissues and promotes revascularization. Thus, Th17 is related to various inflammatory or autoimmune diseases such as bacteriosis, scabies, bronchial asthma, articular rheumatisms, systemic lupus erythematosus (SLE), multiple sclerosis, and transplantation tolerance.
In the present study, we determined the frequency of both Th17 cells and Treg cells in the peripheral blood of pediatric patients with bronchial asthma and food allergies. Our results suggest that Th17 cells and Tregs participate in the pediatric allergic reactions such as bronchial asthma. Patients with bronchial asthma were classified according to the frequency of symptoms (on the basis of Japanese Pediatric Guideline for The Treatment and Management of Asthma 2008) as follows: intermittent, mild, moderate, and severe types. Patients with the intermittent type of asthma showed seasonal and intermittent coughing with a light wheeze that was easily suppressed by the administration of β 2 -agonists. Patients with the mild type showed non-persistent coughing with a light wheeze that occurred more than once a month but less than once a week, and it was sometimes accompanied by difficulty in breathing. Patients with the moderate type of asthma showed persistent coughing with a light wheeze that occurred more than once a week, which was sometimes accompanied by moderate or severe attacks. Patients with the severe type of asthma, who usually have a difficulty in daily life, suffer from persistent coughing with a wheeze several times a week, and on a few times, it is accompanied by moderate or severe, often irremediable, attacks.
MATERIALS AND METHODS

Subjects
We defined recovery from food allergies as the disappearance of the allergic eczema after removal of the corresponding allergen from the patient who had previously shown immediate or chronic allergic reactions after ingestion of the causal food. Allergen-specific RAST scores were determined using the IgE values, which were classified as follows: Class 0 (less than 0.34 IU/ml), Class 1 (0.35-0.69 IU/ml), Class 2 (0.7-3.49 IU/ml), Class 3 (3.50-17.4 IU/ml), Class 4 (17.5-49.9 IU/ml), Class 5 (50.05-99.9 IU/ml), and Class 6 (more than 100 IU/ml).
Patients with asthma included 13 boys and 6 girls (average age: 7.5 years, ranging from 2 to 13.8 years, Table 1 ). They were classified in terms of disease severity into 4 groups: 4 patients were of the intermittent type, 5 patients were of the mild type, 4 patients were of the moderate type, and 6 patients were of the severe type. The periods during which the patients suffered from asthma ranged from 0.6 to 10.3 years, with an average duration of 3.8 years.
Inhalational corticosteroids (ICS) were prescribed for 6 patients; intermittent-type patients received no medication, mild-type patients received an average dose of 75 µg/day, moderate-type patients received an average dose of 225 µg/day, and severe-type patients received an average dose of 433 µg/day. Complications occurred in 3 patients: atopic dermatitis in 2 and allergic rhinitis in 1 ( Table 2) .
Patients with food allergies comprised 7 boys and 1 girl (average age: 2.6 years, ranging from 1.2 to 7.9 years, Table 1 ). Six patients exhibited atopic dermatitis, whereas no complications occurred in the other 2 patients. Serum IgE values ranged from 45.1 to 1188 IU/ml, with an average of 189.5 IU/ml. One patient was allergic to only 1 food, but the other 7 patients were allergic to many foods. The allergypositive foods were eggs for all, milk for 6, wheat for 5, peanuts for 3 and soybeans for 2 patients (Table 3).
Preparation of Peripheral Blood Mononuclear
Cells (PBMC) --Blood samples (4-14 ml) were drawn using an evacuated single-use test tube and were suspended in the same volume of phosphate buffered saline (PBS). This suspension was carefully layered on 5 ml of Lymphoprep and was then successively centrifuged at 500 rpm for 5 min, 1500 rpm for 3 min, and 3600 rpm for 20 min at room temperature. The mononuclear leukocyte layer obtained was collected and centrifuged at 1200 rpm for 10 min at 4 • C. The pellet was suspended in 5 ml PBS, which was used as the PBMC solution.
Detection of Intracellular FOXP3 --The suspension containing 1 × 10 6 cells of the purified PBMCs (CD4 + T cells) was centrifuged at 1800 rpm for 10 min at 4 • C. FOXP3-staining method was in accordance with the previous report. 16) The pellet was suspended in 1 ml of FOXP3-staining so- and kept overnight at 4 • C. After centrifugation, the pellet was suspended in 1 ml of deoxyribonuclease (DNase) I solution and incubated for 30 min at 37 • C. After washing with the FOXP3-staining solution, treatment with DNase I was repeated, and the pellet was washed again with the FOXP3-staining solution. The pellet was blocked for 30 min with 100 µl of 30% goat serum that had been diluted with the FOXP3-staining solution. After centrifugation, the pellet was diluted 25 times of the original PBMC solution with the FOXP3-staining solution containing 30% goat serum. One hundred microliters of mouse anti-human FOXP3 (259D) hybridoma supernatant was added to the mixture, which was incubated for 50-60 min at room temperature and then washed twice with the FOXP3-staining solution. Alexa 488-labeled goat anti-mouse IgG (H+L) was used as the secondary antibody. Secondary antibody solution (100 µl) that had been diluted 800 times with the FOXP3-staining solution containing 30% goat serum was added and then incubated for 1 hr at room temperature. It was then washed twice with the FOXP3-staining solution.
The cell-surface antigens of PBMCs were detected using the procedures described herein. After blocking for 30 min with 100 µl of 10% goat serum, the pellet obtained by centrifugation was reacted for 15 min at room temperature with PE-Cy5 (PC5)-labeled anti-human CD4 (12 µl, Beckman Coulter, Brea, CA, U.S.A.). It was then washed with the FOXP3-staining solution. Detection of IL-17 in T Cells --The suspension containing 1 × 10 6 PBMCs (CD4 + T cells) was centrifuged at 1800 rpm for 15 min at 4 • C. The pellet was suspended in 1 ml of RPMI 1640 containing 10% fetal bovine serum (FBS) and Streptmycin/Penicillin (SM/PC). After addition of ionomycin (final concentration, 2 µg/ml), phorbol myristate acetate (PMA, final concentration, 40 ng/ml), and brefeldin A (final concentration, 40 µg/l), the suspension was incubated at 37 • C for 4 hr with stirring (200 rpm) under 5% CO 2 atmosphere in a polystyrene round tube (5 ml, Falcon BD 352058). The cells were collected and washed twice with the FOXP3-staining solution.
Intracellular FOXP3 was labeled with the fluorescent marker by the in-column staining of cells. The pellet obtained after the final washing, as described above, was then blocked for 30 min with 100 µl of 30% goat serum. After washing, the cell-surface antigen and cytokine were reacted for 20 min at room temperature with various antibodies, such as PC5-labeled anti-human CD4 (12 µl) and Phycoerythrin (PE)-labeled anti-human IL-17 (20 µl, eBioscience, San Diego, CA, U.S.A.) and then washed with FOXP3-staining solution.
IL-17-positive cells in the peripheral blood were detected by stimulating with ionomycin and PMA (an activating reagent for T cells). In humans, it has been reported that transient FOXP3 expression was enhanced by TCR stimulation, 17) this was also observed in our samples as illustrated in Fig. 1a . To avoid artificially increasing the frequency of FOXP3 expression in peripheral blood the FOXP3 data was obtained under unstimulated conditions. 
RESULTS
Frequency of IL-17-positive and FOXP3-positive Cells in the Peripheral Blood
Patients with Asthma: Figure 1a shows a typical correlation plot of the frequencies of IL-17-positive and FOXP3-positive cells, which were detected by double staining of the cells. Thus, it could be showed the frequency of IL17 + FOXP3 − T cells. Patients with asthma showed rather higher frequencies of IL-17-positive cells (2.33 ± 1.29%) than the controls (1.50 ± 0.809%, Fig. 1b) . Severe-type patients tended to show lower frequencies (Figs. 2a and 3a: p = 0.3182, Fig. 3b: p = 0.1655) . The disease duration did not significantly affect the frequency, although patients with asthma consistently exhibited higher frequencies than controls (Fig. 4) .
FOXP3 is the master regulatory gene of Treg and can be used as a specific marker for Treg. The frequency of FOXP3-positive cells (Treg cells) in unstimulated PBMCs was similar between the asthma patients (4.34 ± 0.359%) and the controls (3.85 ± 0.553%). We compared the ratio of IL-17-positive cells (Th17 cells) in stimulated PBMCs with FOXP3-positive cells (Treg cells) in unstimulated PBMCs. A slight trend towards an inverse correlation was obtained in the asthma patients (Fig. 3a , r = −0.2420, p = 0.3182). By excluding the severetype of patients who showed a low frequency of IL-17-positive cells (Fig. 3a) , we increased the trend towards an inverse correlation between percentages of IL-17-positive cells and FOXP3-positive cells Patients with Food Allergy: The frequency of the IL-17-positive cells was 1.53 ± 1.34% in the food allergy patients, which was almost the same as that of the controls (Fig. 1b, p = 0.1558) . The frequency of the FOXP3-positive cells was 4.95 ± 0.553% in the food allergy patients, which was a little higher than that of the controls. The frequencies of the IL-17-positive cells and those of the FOXP3-positive cells showed a strong positive correlation in the food allergy patients (Fig. 3c , r = 0.9034, p = 0.0021).
DISCUSSION
Asthma originates from the immune responses induced by Th2 cells. Th2 cells secrete cytokines that accelerate IgE production and activate eosinophilic leukocytes, eventually causing a predisposition toward chronic inflammation of the lungs where the airways (bronchi) are reversibly narrowed. Recently, a close relationship between IL-17 and allergic diseases was reported in which; that is, IL-17 accelerated the production of cytokines such as IL-6, IL-8, and Chemokine (C-X-C motif) ligand (CXCL) 1 from bronchial fibroblasts or epithelial cells, thereby inducing a positive neutrophil chemotaxis followed by chronic inflammation. 18, 19) In addition, Cheung et al. reported that human eosinophils constantly expressed receptors such as IL-17RA/RC (to IL-17A, F) and IL23R (to IL-23) and that IL-17-and/or IL-23-stimulated eosinophils secreted both chemokines such as CXCL1, CXCL8, and CCL4 as well as cytokines such as IL-1β, IL-6, and IL-17/IL-23. 20) Furthermore, the differentiation of human Th17 was promoted by a combination of cytokines such as IL-1β+IL-23 and IL-1β+IL-6 without any participation of TGF-β, as against the case in mice. 21, 22) IL-17 and IL-23, which are secreted by dendritic cells or macrophages, affect eosinophilic leukocytes and promote the production of cytokines/chemokines together with new Th17 cells causing a vicious cycle that ultimately worsens the allergic inflammation. 23) It has also been reported that IL-17 participated in the manifestation of atopic dermatitis in its acute phase, which is induced either by Th2 when acute or by Th1 when chronic. 24) Our results suggest the participation of Th17 cells during the onset of bronchial asthma even in its early stage, since the frequency of Th17 cells was always high in the peripheral blood independent of disease duration (Fig. 4) . A negative correlation was obtained between the frequencies of Th17 and Treg cells after excluding patients with severe type of asthma (p = 0.1655, Fig. 3b) . The reason why the frequencies of both Th17 and Treg cells in the severe type of patients were as low as those in the controls might be due to the high dose of ICS (433 µg/day) prescribed for severe-type patients, which indicates that steroids could suppress the expression of these cells. The frequency of IL-17-positive cells differed significantly between the male and female patients (Fig. 2b) . This might be due to developmental differences in respiratory organs because the average age of females in our study was 3 years more than that of male patients.
Shreffler et al. reported that patients with a milk allergy who acquired tolerance to heated milk exhibited a higher frequency of Treg cells that reacted specifically with the antigen in milk than did patients who did not acquire this tolerance for heated milk and that the former usually showed mild allergy symptoms and convalesced satisfactorily. 23) It was also reported that the frequency balance between Th17 cells and Treg cells was important in the suppression of intestinal inflammation and that IL-23 promoted the differentiation of Th17 cells and suppressed the induction of Treg cells. 25) Our results indicated that the frequencies of both Th17 and Treg cells were substantially higher in 3 of the 8 patients with food allergies than those in the controls (Figs. 1b and 3c) . The symptoms of the other 5 patients were easily relieved by the subsequent medical treatment, indicating that the frequencies of both cell types in these patients were similar to those in the controls. Positive trend was shown between the frequencies of Th17 and Treg cells in the patients with food allergies (Fig. 3c) , which was in contrast to the negative correlation observed in the patients with asthma ( Fig. 3a and 3b) . This might be due to differences between bronchial and intestinal inflammation. However, a few cases showed high frequency of FOXP3-positive and IL-17-positive cells, even among the asthma patients. Our study was performed using a limited number of subjects and thus its robustness should be further investigated in a larger study.
Deknuydt et al. 26) and Voo et al. 27) found that Treg cells could be converted into Th17 cells in the inflammatory tissues by a Th17 cell stimulation in the presence of IL-2. This conversion was accomplished using both the natural naive Treg cells and memory T cells. This phenomenon suggests a partial conversion of FOXP3-positive cells into IL-17-producing cells in the inflammatory tissues as a way to balance the activities of Th17 and Treg cells.
Thus, in the present study, we elucidated the participation of Th17 and Treg cells in pediatric patients with bronchial asthma or food allergies. To further clarify the immunological functions of these 2 cells, it will be necessary to examine many more cases of allergic diseases, including asthma, food allergies, atopic dermatitis, allergic rhinitis, and others.
